Unlock the advantage of time

Technologies that smartly integrate across the Breast Health Continuum of Care

From screening to monitoring, our clinically proven innovations support you in delivering excellence in disease management all along the patient pathway.

Watch Video

Achieving optimal workflow effciency across the Breast Health Continuum of Care

Time is precious when it comes to effective detection, diagnosis and treatment of breast cancer.

We strive to save you time at every step along the Breast Health Continuum of Care ensuring more women have more time in better health.

Our pioneering integrated technologies are designed to help you deliver maximum clinical confidence and workflow efficiency across the patient pathway. Harnessing innovative technologies to advance earlier diagnosis and support a compassionate, minimally invasive approach to patient care.

Our technology is powered by 30 years of Hologic’s breast health expertise in delivering smart solutions to complex diagnostic and treatment needs.

We are driven to deliver better outcomes for women giving them more time in better health, from screening all the way to treatment and monitoring – explore how

Radiology

Pioneering improvements in image quality to enable confident diagnosis, faster and more effciently

Breast Surgery

Intraoperative localization and specimen imaging solutions for better workflow effciency between radiologists and surgeons

Pathology

Quicker verification right in the pathology laboratory results in faster completion time

Monitoring

Pioneering solutions at the forefront of image quality and precision to address long-term impacts
Radiology Screening
Diagnosis
Biopsy
Breast Surgery Localize
SLN Biopsy*
Filling and Marking**
Pathology Specimen Evaluation
Monitoring Bone Health
Artificial intelligence
Breast Screening

With 3Dimensions™ Mammography system you have access to the industry’s fastest, highest resolution and most accurate 3D Mammography system ever, that is designed to improve patient comfort. By utilising Genius AI™ technology, 3Dimensions™ can help you improve detection of breast cancers and reduce call backs.1-7

Explore our full Screening Portfolio
Analytics, Detection and Diagnosis

Through innovative AI algorithms we offer breast diagnostic and analytics solutions to help improve detection rates, including I-View™ 2.0 Contrast Imaging, Quantra™ 2.2 Breast Density Assessment and ImageChecker® CAD Technology. Our Supersonic MACH Ultrasound Series leverages UltraFast™ Imaging Technology, with the option of adding additional modes like ShearWave™ PLUS, TriVu, and Needle PLUS, to enhance overall diagnostic accuracy. And because such powerful solutions require integrated, streamlined and breast-specific workflows, we provide Unifi™ Workspace, SecurView® and SecurXchange® too.

Discover our intergrated screening porfolio Discover Supersonic Ultrasound
Breast Biopsy

Our Affirm® Upright and Affirm® Prone Breast Biopsy Systems, together with the Brevera® Breast Biopsy System deliver a compassionate patient experience, reduce time under compression and help clinicians deliver the best outcomes possible.

See all of our breast biopsy solutions
Localize in Breast Surgery

LOCalizer is a revolutionary way to guide breast surgeries easily and precisely. No radioactivity, no surgical wires. The LOCalizer system is designed to be implanted into the breast any time prior to surgery, so no more localization scheduling conflicts for your team.

Discover LOCalizer™
Sentinel Lymph Node Biopsy*

The TruNode® system is a high performance, wireless gamma probe, commonly used for sentinel lymph node biopsy. It is designed to be more accurate and less invasive than the most common radio-guided surgical probes.

Discover TruNode®
Removal, Filling and Marking**

With BioZorb® 3D Bioabsorbale Marker, the future of tumor-site marking is taking shape-in 3D. It is designed to provide precise marking of the tumor excision site before its framework is absorbed into the body over several years, to yield excellent cosmetic outcomes

Discover BioZorb®
Specimen Evaluation

The Faxitron® Specimen Radiography portfolio enables you to streamline your radiology, surgery and pathology workflow. The high-resolution quality images enable you to have immediate verification and make informed clinical decisions on biopsy and surgical specimens, right there on the spot.

Discover the Faxitron® Specimen Radiography portfolio
Monitoring Bone Health and Body Composition

Breast cancer and associated treatments have a high impact on patients. The Horizon® DXA system enables a close monitoring of Bone Mineral Density, assessments of vertebral fracture and fat/lean distribution, to enrich the quality of your diagnosis and the quality of your patient's life.

Discover the Horizon® DXA System

*TruNode® is available in selected markets only.
**BioZorb® is not CE marked. Not for sale. Not for distribution.

Unlock the Advantage of time – across the entire Breast Health Continuum of Care

References
  1. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.
  2. Data On File: DHM-06039 Rev 002 Jennifer Bartoshevich, Teri Orefice, Sajjad Mansoor, et.al Internal Study comparing Hologic®’s flat paddle to the SmartCurve™ paddle (18x24cm) (2017).
  3. Rafferty EA, Durand MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA. 2016 Apr 26;315(16):1784-6.
  4. Smith A. Improving patient comfort in mammorgraphy. WP-00119 Rev 003 (11/17). Available at https://www.hologic.com/sites/default/files/Improving%20Patient%20Comfort%20In%20Mammography.pdf
  5. Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.
  6. McDonald ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737-43.
  7. Harvey JA, Fajardo LL, Innis CA. AJR 1993; 161:1167-1172 Previous Mammograms in Patients with Impalpable Breast Carcinoma: Retrospective vs Blinded Interpretation
ce mark
0050 TruNode® 2797 All Other Products
EC REP
Hologic BV, DA Vincilaan 5,
1930 Zaventem, Belgium

Product Notice

You are about to access medical systems information on the Hologic 3Dimensions™ Mammography System European Website. Product availability differs by region and country and is subject to varied regulatory requirements.

The content of this site is reserved for Health Care Professionals only.

I am a Health Care Professional or similar.

Je suis un professionnel de santé ou assimilé.

Je ne suis pas un professionnel de santé ou assimilé.